Avenir Corp - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 176 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2024. The put-call ratio across all filers is 6.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
Avenir Corp ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q2 2024$276,441
+29.8%
76,365
+15.1%
0.03%
+50.0%
Q1 2024$213,032
-34.5%
66,3650.0%0.02%
-35.7%
Q4 2023$325,189
+95.2%
66,365
+117.1%
0.03%
+75.0%
Q3 2023$166,579
-18.8%
30,5650.0%0.02%
-11.1%
Q2 2023$205,091
-24.2%
30,565
-0.3%
0.02%
-30.8%
Q1 2023$270,640
+15.6%
30,6500.0%0.03%
+13.0%
Q4 2022$234,166
+7.4%
30,6500.0%0.02%0.0%
Q3 2022$218,000
-50.2%
30,650
-43.3%
0.02%
-45.2%
Q2 2022$438,000
+8.7%
54,100
+86.6%
0.04%
+31.2%
Q1 2022$403,000
-48.7%
29,000
+3.6%
0.03%
-47.5%
Q4 2021$786,000
-17.4%
28,0000.0%0.06%
-23.8%
Q3 2021$952,000
-16.8%
28,0000.0%0.08%
-12.1%
Q2 2021$1,144,000
+1.5%
28,0000.0%0.09%
-6.2%
Q1 2021$1,127,000
-31.9%
28,0000.0%0.10%
-38.6%
Q4 2020$1,656,000
+21.6%
28,0000.0%0.16%
+11.3%
Q3 2020$1,362,000
+0.5%
28,0000.0%0.14%
-7.8%
Q2 2020$1,355,00028,0000.15%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q2 2024
NameSharesValueWeighting ↓
Eagle Health Investments LP 1,014,860$14,086,0003.47%
Triatomic Management LP 297,048$4,123,0003.35%
Diametric Capital, LP 265,000$3,678,0002.03%
Matrix Capital Management Company, LP 11,572,590$160,628,0001.93%
VIKING GLOBAL INVESTORS LP 29,993,708$416,313,0001.68%
TIGER MANAGEMENT L.L.C. 589,311$8,180,0001.35%
Aristotle Atlantic Partners, LLC 759,412$10,541,0000.65%
Casdin Capital, LLC 1,000,000$13,880,0000.62%
Pier Capital, LLC 339,541$4,713,0000.60%
Leeward Financial Partners, LLC 68,504$951,0000.59%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders